Prosecution Insights
Last updated: April 19, 2026

Examiner: GOLOVAN, MARK

Tech Center 3700 • Art Units: 3783

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-70.0% vs TC avg
16
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
25.0%
§102 Novelty
43.8%
§103 Obviousness
31.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18328695 SYSTEM AND METHOD FOR DELIVERING A FLUID FROM A CONTAINER TO AN INFUSION LINE Non-Final OA CareFusion 303, Inc.
18236132 Vascular Access Instrument Non-Final OA Becton, Dickinson and Company
18221655 Blood Collection Device with Variable-Diameter Fluid Flow Conduit Non-Final OA Becton, Dickinson and Company
18329375 SYSTEMS AND METHODS FOR SUBSTANTIALLY CONTINUOUS INTRAVENOUS INFUSION OF THE SAME OR SUBSTANTIALLY THE SAME MEDICAL FLUID WITH FLUID SOURCE REPLACEMENTS Non-Final OA ICU Medical, Inc.
18115316 INSULIN INFUSION SET Final Rejection Tandem Diabetes Care, Inc.
18325913 SYSTEMS AND METHODS FOR DETERMINING USAGE OF BALANCED SALT SOLUTION IN AN OPHTHALMIC SURGICAL SYSTEM Non-Final OA Johnson & Johnson Surgical Vision, Inc.
18370999 CATHETER STABILIZER AND GRIP Non-Final OA KUSMO, INC.
18237040 RESERVOIR ASSEMBLY AND DRUG SOLUTION INJECTION DEVICE COMPRISING SAME Non-Final OA EOFLOW CO., LTD.
18127653 DEVICE FOR NEEDLE-FREE INJECTION OF A FLUID Non-Final OA Henke-Sass, Wolf GmbH
17741927 RESERVOIR STATE MONITORING Final Rejection LTS DEVICE TECHNOLOGIES LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month